跳至主要内容
临床试验/NCT06611527
NCT06611527招募中不适用

Comparison Between Two Methods of Positive Pressure Therapy in the Prevention of Pulmonary Complications in the Immediate Postoperative Period of Cardiac Surgery: a Prospective, Randomized Clinical Trial

Federal University of São Paulo1 个研究点 分布在 1 个国家目标入组 156 人开始时间: 2025年1月8日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
156
试验地点
1
主要终点
Severity of pulmonary complications in the postoperative period

研究概览

简要总结

The most common cardiac surgeries are myocardial revascularization and valve replacement or plastic surgery. In the postoperative period of cardiac surgeries, the incidence of pulmonary complications ranges from 30% to 50% and is associated with increased length of hospital stay and morbidity and mortality. To reduce or minimize the occurrence of these complications, respiratory physiotherapy employs positive pressure reexpansion therapies, such as continuous positive airway pressure (CPAP) and positive pressure support with positive end-expiratory pressure (PS+PEEP).

The goal of this clinical trial is to compare the effects of two positive pressure therapies, CPAP versus PS+PEEP, on the incidence of pulmonary complications in patients in the postoperative period of myocardial revascularization and valve replacement or plastic surgery, with mild to moderate pulmonary dysfunction.

The main question it aims to answer is: Do patients in the immediate postoperative period of myocardial revascularization or valve replacement/plastic surgery, exhibiting mild to moderate pulmonary dysfunction, experience a comparable reversal of pulmonary conditions when treated with PS+PEEP versus CPAP?

Participants will undergo the following assessments: spirometry, respiratory muscle strength testing, handgrip strength testing, and electrical impedance tomography.

In the immediate postoperative period, participants will be randomized into two treatment groups: • Control Group PS+PEEP - application of 4 sets of 20 repetitions with PS to provide a tidal volume equal to 10ml/kg of predicted body weight, PEEP equal to 10 cmH2O, and inspired oxygen fraction (FiO2) to achieve peripheral oxygen saturation (SpO2) between 92-94%; • Experimental Group CPAP - application of CPAP at 10 cmH2O with FiO2 to achieve SpO2 between 92-94% for 30 minutes.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Immediate postoperative period of myocardial revascularization and/or valve replacement or plastic surgery;
  • •Patients in the preoperative period at risk of developing pulmonary complications, characterized by the presence of at least 2 of the following risk factors: age ≥ 70 years, productive cough, diabetes, history of smoking, chronic obstructive pulmonary disease (COPD) defined by forced expiratory volume in 1 second (FEV1) lower than 75% of predicted, body mass index (BMI) ≥ 27 kg/m2, or only FEV1 lower than 80% and FEV1/forced vital capacity (FVC) ratio lower than 70% of predicted; OR patients in the postoperative period (up to 12 hours after extubation) with mild to moderate complications characterized by a pulmonary complication score lower than 3.

排除标准

  • •Hemodynamic instability characterized by mean arterial pressure (MAP) lower than 60mmHg and/or acute arrhythmia of any etiology;
  • •Need for intra-aortic balloon;
  • •Duration of invasive mechanical ventilation exceeding 24 hours after surgery;
  • •Pulmonary complication score ≥ grade 3;
  • •Presence of signs of acute respiratory failure, such as respiratory rate (f) ≥ 25 breaths/min and use of accessory muscles;
  • •Chest tube with air leak;
  • •Use of a pacemaker or implantable or external cardioverter-defibrillator.

研究组 & 干预措施

PS+PEEP group

Active Comparator

PS+PEEP modality involves the application of two levels of positive pressure intermittently.

干预措施: PS+PEEP group (Device)

CPAP group

Experimental

Continuous positive airway pressure modality.

干预措施: CPAP group (Device)

结局指标

主要结局

Severity of pulmonary complications in the postoperative period

时间窗: Participants will be followed for 7 days after surgery.

Score of pulmonary complications adapted from previous publications, with 5 degrees, where the higher one (5) means death before hospital discharge, and degree 4 means need of invasive mechanical ventilation due to acute respiratory failure.

Electrical impedance tomography (EIT) ventilation distribution

时间窗: EIT ventilation distribution will be monitored during and 30 minutes after the therapies.

次要结局

  • Maximal inspiratory and expiratory pressures(Assessments will be conducted preoperatively, on the 5th and 7th postoperative days.)
  • Length of ICU stay(From the day of surgery up to ICU discharge, an expected average of 2 days, and maximum censoring at day 28 after surgery.)
  • Length of hospital stay(From the day of surgery up to hospital discharge, an expected average of 10 days, and maximum censoring at day 28 after surgery.)
  • Handgrip strength(Assessments will be conducted preoperatively, on the 5th and 7th postoperative days.)
  • Spirometry test results(Spirometry will be conducted preoperatively, on the 5th and 7th postoperative days.)
  • Positive pressure therapy comfort level(The level of comfort will be evaluated immediately after the first three positive pressure therapy sessions.)

研究者

发起方
Federal University of São Paulo
申办方类型
Other
责任方
Principal Investigator
主要研究者

Marcia Souza Volpe

Professor

Federal University of São Paulo

研究点 (1)

Loading locations...

相似试验